Cloud AI Today - Healthcare AI Spending Surges Transforming Drug Development Simply Wall St Tue, November 17, 2026 at 7:37 AM EST 2 min read GOOG -0.14% MSFT -0.34% AAPL -0.08% Explore stocks on Coinbase Trading disclosure Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Menlo Ventures' 2026 State of AI in Healthcare report highlights a significant shift in healthcare AI spending, reaching $3.7 billion—an increase of 2.5 times over the past year. This growth indicates a transition from administrative functions to more critical applications, such as drug discovery, clinical decision-making, and patient care. AI spending in life sciences grew 23-fold, suggesting pharmaceutical companies are increasingly relying on AI to expedite drug development processes. This report underscores the expanding role of AI in transforming healthcare, pointing towards a future where AI plays a pivotal role in improving health outcomes and reducing costs.
Elsewhere in the market, HubSpot was trading firmly up 6.8% and closing at $231.98. At the same time, IREN softened, down 9.8% to close at $16.39, not far from its 52-week low.
HubSpot is rapidly integrating AI into its CRM platform to capitalize on growth opportunities among larger enterprise clients. Discover more about HubSpot's strategic moves by exploring the complete narrative on the company's potential.
For a timely and insightful examination of the role DRAM plays in the Cloud AI cycle, revisit our Market Insights article on memory stocks and market cycles—don't miss out.
Apple ended the day at $352.78 down 1%, close to the 52-week high.
Microsoft ended the day at $517.99 down 1.1%.
Alphabet settled at $283.72 down 4.1%, close to the 52-week low.
Discover the full array of 149 Cloud AI Stocks, featuring Autodesk, Tata Consultancy Services and King Slide Works, right here.
Searching for a Fresh Perspective? The end of cancer? These 40 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
"Menlo Ventures' 2026 State of AI in Healthcare Report: Healthcare AI Spending Hits $3.7B, Up 2.5x as Growth Shifts From Paperwork to Drug Discovery and Patient Care" from Menlo Ventures on GlobeNewswire (published 16 November 2026)
Companies discussed in this article include NYSE:HUBS NasdaqGS:AAPL NasdaqGS:MSFT NasdaqGS:GOOGL and NasdaqGS:IREN.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com